Publication Name	World Journal of Gastroenterology
Manuscript ID	87288
Country	United States

Received	2023-08-09 13:46
Peer-Review Started	2023-08-01 23:29
To Make the First Decision
Return for Revision	2023-09-28 02:55
Revised	2023-10-15 19:06
Second Decision	2023-11-06 05:23
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-11-09 07:18
Articles in Press	2023-11-09 07:18
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-11-14 01:01
Publish the Manuscript Online	2023-11-20 06:17

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Pediatric-type follicular lymphoma in a Crohn’s disease patient receiving anti-α4β7-integrin therapy: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Keval Yerigeri and Ilia Buhtoiarov
Funding Agency and Grant Number
Corresponding Author	Keval Yerigeri, MD, Doctor, Internal Medicine-Pediatrics, Case Western Reserve University/MetroHealth, 2500 Metrohealth Dr, Cleveland, OH 44109, United States. kyerigeri@metrohealth.org
Key Words	Pediatric-type follicular lymphoma; Crohn’s disease; Vedolizumab; Immunosuppression; Non-Hodgkin lymphoma; Case report
Core Tip	The literature is inconclusive on the association between anti-α4β7-integrin therapy and oncogenesis. This case report highlights a young adult on chronic vedolizumab, a monoclonal antibody targeting α4β7-integrin, who develops pediatric-type follicular lymphoma. The patient recovered with rituximab, cyclophosphamide, vincristine, prednisone immunotherapy, but T-lymphocyte mitogen response remained suppressed.
Publish Date	2023-11-20 06:17
Citation	Yerigeri K, Buhtoiarov I. Pediatric-type follicular lymphoma in a Crohn’s disease patient receiving anti-α4β7-integrin therapy: A case report. World J Gastroenterol 2023; 29(43): 5865-5871
URL	https://www.wjgnet.com/1007-9327/full/v29/i43/5865.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i43.5865

Full Article (PDF)	WJG-29-5865-with-cover.pdf
Full Article (Word)	WJG-29-5865.docx
CARE Checklist–2016	87288-CARE Checklist (2016).pdf
Manuscript File	87288_Auto_Edited-JLW.docx
Answering Reviewers	87288-Answering reviewers.pdf
Audio Core Tip	87288-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	87288-Conflict-of-interest statement.pdf
Copyright License Agreement	87288-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	87288-Informed consent statement.pdf
Peer-review Report	87288-Peer-review(s).pdf
Scientific Misconduct Check	87288-Bing-Wang JJ-2.png
Scientific Editor Work List	87288-Scientific editor work list.pdf